AIB Group PLC
31 July 2026
31 July 2026
AIB Group plc
Transaction in Own Shares
AIB Group plc ("AIB" or the "Company") announces that from 27 July 2026 to 31 July 2026, it purchased a total of 2,575,000 of its ordinary shares of EUR 0.625 each ("Ordinary Shares") on Euronext Dublin through Goodbody Stockbrokers UC ("Goodbody"), as detailed below. The purchases form part of the Company's €1.0 billion share buyback programme announced on 4 March 2026. The repurchased shares will be cancelled.
|
Date of purchase |
Number of ordinary shares purchased |
Highest price paid (per ordinary share) |
Lowest price paid (per ordinary share) |
Volume weighted average price paid (per ordinary share) |
|
27 July 2026 |
500,000 |
10.97 |
10.83 |
10.9189 |
|
28 July 2026 |
500,000 |
10.94 |
10.72 |
10.8350 |
|
29 July 2026 |
400,000 |
10.80 |
10.54 |
10.6036 |
|
30 July 2026 |
625,000 |
10.43 |
10.17 |
10.3047 |
|
31 July 2026 |
550,000 |
10.51 |
10.25 |
10.3435 |
Following cancellation of the repurchased shares above, the Company's total number of Ordinary Shares in issue shall be 2,083,411,363, each carrying the right to one vote. The Company holds nil Ordinary Shares in treasury.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades made by Goodbody on behalf of the Company as part of the share buyback programme can be found at:
http://www.rns-pdf.londonstockexchange.com/rns/8587O_1-2026-7-31.pdf
For further information, please contact:
|
Niamh Hore / Siobhain Walsh Investor Relations AIB Group plc Dublin Tel: +353-86-3135647 / +353-87-3956864 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.